Table 4.
Interaction of Lp(a) with gender on IR on additive and multiplicative scale.
| Lp(a) | RERI (95%CI) | P | Product term OR (95%CI) | P |
|---|---|---|---|---|
| Q4(<21.95mg/dL) | 0.19(-0.19~0.58) | 0.32 | 1.18(0.82~1.70) | 0.36 |
| Q3(≤10.8mg/dL) | 0.13(-0.28~0.53) | 0.54 | 1.09(0.76~1.57) | 0.62 |
| Q2(≤6.5mg/dL) | 0.04(-0.39~0.48) | 0.85 | 1.01(0.71~1.45) | 0.94 |
| Q1(≤3.7mg/dL) | 0.81(0.33~1.28) | <0.01 | 1.62(1.13~2.30) | 0.01 |
RERI, relative excess risk due to interaction. Adjustment as in Table 2 .